Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.Circulation|November 15, 2013
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.Heart (British Cardiac Society)|February 6, 2016
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary interventionMatthijs A Velders, Jérémie Abtan, Dominick J Angiolillo, et al.European Heart Journal|April 1, 2014
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan K James, Richard G Bach, et al.Journal of the American College of Cardiology|September 24, 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinZiad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.Journal of the American College of Cardiology|November 12, 2013
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)Greg Flaker, Renato D Lopes, Sana M Al-Khatib, et al.European Heart Journal|November 18, 2011
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialRichard C Becker, Jean Pierre Bassand, Andrzej Budaj, et al.Pageof 10